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ABSTRACT
Natural products continue to represent the main source for therapeutics, and ethnopharmacological remedies from high biodiversity regions are a rich source for the development of novel drugs. Hence, in our attempt to find new anti-neoplastic activities we focused on ethnomedicinal plants of the Maya, who live in the world's third richest area in vascular plant species. Pluchea odorata (Asteraceae) is traditionally used for the treatment of various inflammatory disorders and recently, the in vitro anti-cancer activities of different extracts of this plant were described. Here, we present the results of bioassay-guided fractionations of the dichloromethane extract of P. odorata that aimed to enrich the active principles. The separation resulted in fractions which showed the dissociation of two distinct anti-neoplastic mechanisms; firstly, a genotoxic effect that was accompanied by tubulin polymerization, cell cycle arrest, and apoptosis (fraction F2/11), and secondly, an effect that interfered with the orchestrated expression of Cyclin D1, Cdc25A, and Cdc2 and that also led to cell cycle arrest and apoptosis (fraction F3/4). Thus, the elimination of generally toxic properties and beyond that the development of active principles of P. odorata, which disturb cancer cell cycle progression, are of interest for potential future therapeutic concepts against proliferative diseases.
INTRODUCTION
The majority of medicinal drugs used in western medicine are derived from natural products (1, 2) . A success story in natural product drug discovery is paclitaxel (Taxol), which is derived from the bark of the Pacific Yew, Taxus brevifolia Nutt. (Taxaceae). The antitumor activity of Taxol is based on its ability to stabilize microtubules in tumor cells, triggering mitotic arrest and cell death (3) (4) (5) . Several Native American tribes have used Taxus species for the treatment of non-cancerous diseases (6) . Ethnopharmacological remedies, particularly from high biodiversity regions such as rainforests, can be a rich source for the development of novel drugs (7) and therefore, we investigate traditional healing plants of the Maya who live in a region which is the world's third richest in vascular plant species (8) . Over the centuries and millennia, the Maya developed an advanced pharmaceutical knowledge that is still practiced today. In the attempt to find plants with anti-neoplastic activities we select those traditionally used against severe inflammations, because there are several similar signaling pathways, which are commonly up-regulated in both, in inflammatory conditions and in cancer (9) . Maya healers prepare decoctions of the Asteraceae Pluchea odorata (L.) Cass. (Itza-Maya vernacular name: "Chal Che"), to treat coughs, cold, neuritis, and arthritis and also swelling, bruises, Fractionation of the Pluchea odorata CH 2 Cl 2 crude extract by VLC. The CH 2 Cl 2 extract was chromatographed on a silica gel column using the indicated solvents as mobile phase, which resulted in 10 fractions (F1/1 -F1/10). Fractionation of the Pluchea odorata F1/3 extract by column chromatography (CC-I). The extract was applied on a silica gel column and eluted with the indicated solvents and 21 main fractions (F2/1 -F2/21) were obtained. Chlorophyll was removed from fractions F2/11-16 and the fraction-yield (mg, %) before and after chlorophyll separation was calculated.
inflammations, and tumors (10) . Recently, the anti-cancer activity of extracts of this medicinal herb was described (11) . Here, we focused on the dichloromethane extract of P. odorata and performed bioassay-guided fractionations to separate and enrich different bioactive principles. 
MATERIALS AND METHODS
Plant material
Extraction and fractionation
Aerial plant parts of P. odorata were lyophilised, ground and 192 g were taken for extraction using an accelerated solvent extractor (ASE) ( Fractionation of the Pluchea odorata F2/13 extract by column chromatography (CC-II). The extract was chromatographed on a silica gel column using the indicated solvents as mobile phase; the separation resulted in 5 main fractions (F3/1 -F3/5).
Cell Culture
HL-60 promyelocytic leukaemia cells were purchased from ATCC and grown in RPMI 1640 medium and humidified atmosphere containing 5% CO 2 at 37°C. The medium was supplemented with 10 % heat-inactivated fetal calf serum (FCS), 1 % Glutamax and 1 % PenicillinStreptomycin. The medium and supplements were obtained from Life Technologies (Carlsbad, CA, USA).
Proliferation inhibition analysis
HL-60 cells were seeded in T-25 tissue culture flasks or in 24-well plates at a concentration of 1 x 10 5 cells/ml and incubated with increasing concentrations of plant extracts or fractions. Cell counts and IC 50 values were determined within 24 h using a KX-21 N microcell counter (Sysmex Corporation, Kobe, Japan). All experiments were performed in triplicate. Cell proliferation rates were calculated as described (11-13).
Cell death analysis
In order to determine the type of cell death, HL-60 cells were seeded in 24-well plates at a concentration of 1 x 10 5 cells/ml and grown for 24 h. Then cells were treated with the indicated concentrations of the extract and fractions for 8 h and 24 h. Hoechst 33258 and propidium iodide were added to the cells at final concentrations of 5 and 2 µg/ml, respectively. After 1 h of incubation at 37°C, cells were examined on a Zeiss Axiovert fluorescence microscope equipped with a DAPI filter. Cells were photographed and analyzed by visual examination to distinguish between apoptosis and necrosis (14) (15) (16) . For this, cells were judged according to their morphology and the integrity of the plasma membrane on the basis of propidium iodide exclusion. Experiments were performed in triplicate.
Western blot analysis
HL-60 cells were seeded in T-75 tissue culture flasks at a concentration of 1 x 10 6 cells/ml and incubated with 3 µg/ml fractions (F2/11, F2/13, F3/4, respectively) for 0.5 h, 2 h, 4 h, 8 h and 24 h. At each time point, 2 x 10 6 cells were harvested, placed on ice, centrifuged (1000 rpm, 4 ºC, 4 min), washed twice with cold PBS (pH 7.2), and lysed in 150 µl buffer containing 150 mM NaCl, 50 mM Tris pH 8.0, 1 % Triton X-100, 1mM phenylmethylsulfonylfluorid (PMSF) and Protease Inhibitor Cocktail (Sigma, Schnelldorf, Germany). Debris was removed by centrifugation (12,000 rpm, 4 ºC, 20 min) and equal amounts of total protein were electrophoretically separated by SDS polyacrylamide gels (10 %) and then transferred to PVDF membranes (Hybond P, Amersham, Buckinghamshire, UK) at 100 V and 4ºC for 1 h. To confirm equal sample loading, membranes were stained with Ponceau S (17) (18) (19) . Customary blotting protocol was employed; primary antibodies were diluted 1:500 in blocking solution and incubated with the membrane at 4 ºC, overnight and the secondary antibodies were diluted 1:2000. Blots were analyzed using an enhanced chemoluminescence technique (ECL detection kit) and detected by exposure of the membranes to Amersham Hyperfilm TM (both Amersham, Buckinghamshire, UK). The antibody against PhosphoCdc25A (S75) was from Abcam (Cambridge, MA, USA) and against phospho-Cdc25A (S177) from Abgent (San Diego, CA, USA). Anti-gamma-H2AX (pSer139) was purchased from Calbiochem (San Diego, CA, USA) and the antibodies against cleaved caspase-3 (Asp175), Chk2, phospho-Chk2 and phospho-Cdc2 (Tyr15) from Cell Signaling (Danvers, MA, USA). The antibodies against Cdc2 p34 (17), Cdc25A (F-6), Cyclin D1 (M-20), PARP-1 (F-2) and alpha-tubulin (DM1A) were from Santa Cruz Biotechnology Inc. (Santa Cruz, CA, USA) and the antibodies against beta-actin (clone 6-11B-1) and acetylated alpha-tubulin (clone 6-11B-1) were from Sigma (St. Louis, MO, USA). The secondary antibodies peroxidaseconjugated anti-rabbit IgG and anti-mouse IgG were purchased from Dako (Glostrup, Denmark).
Statistical analysis
The apoptosis and proliferation experiments were analyzed by t-test using GraphPad Prism version 4 (GraphPad Prim Sofware, Inc., San Diego, CA, USA).
RESULTS AND DISCUSSION
Anti-proliferative activity of Pluchea odorata CH 2 Cl 2 crude extract and F1 (VLC) fractions
The activity of the obtained CH 2 Cl 2 crude extract, which was 2.1 % of the dried plant material input (196 g), was tested in HL-60 leukemia cells. Cells were incubated with increasing concentrations of crude extract (1-15 µg/ml) and the number of cells was counted twice within a time span of 24 h in order to calculate the proliferation rates. The CH 2 Cl 2 crude extract significantly decreased the proliferation rate of HL-60 cells; the concentration which inhibited cell proliferation by 50 % (IC 50 ) was ~10 µg/ml ( Figure 1) . Subsequently, the crude extract was fractionated by VLC resulting in fraction F1/1 -F1/10 ( Table 1 ). All fractions were tested at concentrations of 10µg/ml. The results showed that fraction F1/3, which represented 36.5 % of the CH 2 Cl 2 extract input (4.0 g), inhibited proliferation by ~ 60 %, whereas the other fractions had no effect on cell growth (data not shown). Therefore, the gain of activity was not significant and VLC was an insufficient procedure to enrich the active principles. Based on these results, subsequent fractionation of F1/3 by CC-I followed.
Anti-proliferative activity of F2 (CC-I) fractions derived from F1/3
Fraction F1/3 was further subjected to CC-I to provide 21 main fractions ( Table 2 ). The anti-proliferative . In order to exclude the possibility that chlorophyll contributed to the anti-proliferative effect, fractions F2/11 -F2/16 were subjected to separation of chlorophyll and then re-evaluated for activity. The results indicated that the anti-proliferative activity was preserved in the chlorophyll-free fractions (Figure 2b) . Moreover, the effect of fraction F2/14 was increased after the removal of chlorophyll.
Anti-proliferative activity of F3 (CC-II) fractions derived from F2/13
Since CC-I fractionation was successful in enriching the anti-proliferative activity, we then selected one of the most active chlorophyll-free fractions for further fractionation. Fraction F2/13 contained the least restrictive amount of material, which was 2.8 % of the F1/3 input (1.46 g). Hence, fraction F2/13 was subjected to a second step CC separation (CC-II). Based on similarities of the TLC profile, five main fractions (F3/1 -F3/5) were obtained (Table 3) . In order to determine the antiproliferative effect, HL-60 cells were treated with the indicated concentrations of fractions (Figure 3) . The results suggested fraction F3/4 to be the most potent of the F3 fractions. Fraction F3/4 inhibited proliferation with a calculated IC 50 of ~0.4 µg/ml; therefore, the increase of the activity compared to the crude extract was ~25-fold.
Additional separations of F3 fractions with reversed phase solid phase extraction resulted in decreased bio-activities (data not shown). Therefore, these fractions seemed to separate different active principles that were additive in F3/4. This evidences that controlled multicompound preparations of plant extracts, such as F3/4 or i.e. Avemar (20) , can be more effective than isolated single compounds. The attempt to identify these active principles would have exceeded the frame of this investigation.
Western blot analysis of cell cycle and checkpoint regulators
Fractions F2/11, F2/13 and F3/4 showed the highest anti-proliferative activity. Hence, their effect on the expression of cell cycle regulatory proteins was analyzed by Western blotting, because protagonists such as the proto-oncogenes Cyclin D1 and Cdc25A, which are both up-regulated in hyper-proliferative diseases, are goals for new anti-neoplastic therapies (21, 22) . The lowest common concentration of fractions F2/11, F2/13 and F3/4, which completely inhibited HL-60 cell proliferation, was 3 µg/ml and therefore, the following analyses were performed with this concentration. Fraction F2/11 suppressed Cyclin D1 expression after 24 h, whereas F2/13 reduced the Cyclin D1 level after 8 h and its derivative fraction F3/4 already after 30 minutes (Figure 4 ). Temporally the D-family of cyclins appears in early G1 of the cell cycle (23) (24) (25) and Cyclin D1 is required for the activation of Cdk4 and Cdk6 (21, 26) and it is also known as the Prad1 proto-oncogene (27) .
The intra-S-phase checkpoint prevents the duplication of damaged or broken DNA which would eventually lead to genomic instability. This checkpoint is i.e. regulated by ATM/ATR-Chk2-Chk1-Cdc25A (28) . Depending on the type of DNA damage (genotoxic stress), ATM or ATR phosphorylates Chk2 or Chk1, which in turn phosphorylates Cdc25A (29, 30) . Thereby, Cdc25A becomes inactivated and causes the inhibition of Cdk2 and Cdc2 (31). Here we demonstrate that Chk2 was phosphorylated at the activating Thr68 site upon treatment with all three tested fractions. F2/11 caused a rapid and transient phosphorylation of Chk2 within 2 h, which returned to constitutive levels after 24 h. In contrast, fraction F2/13 induced phosphorylation of Chk2 after 24 h and fraction F3/4 after 8 h which sustained for 24 h. Therefore, activation of Chk2 by F3/4 was not transient and was caused by a different trigger than by F2/11. Chk2 protein levels remained unchanged upon incubation with F2/13 and F3/4, but the level decreased upon incubation with F2/11 after 24 h (Figure 4 ). The analysis of Chk2 phosphorylation-and protein levels supported the notion that different active principles are contained in F2/11 compared to F2/13 and its derivative F3/4. The activation of Chk2 by F2/11 was the earliest effect observed in this protein expression study, whereas it was the latest event upon treatment with F2/13 and F3/4. The rapid Chk2 induction indicated that F2/11 caused DNA damage, which was supported by the fact that the phosphorylation of H2AX (gamma-H2AX) was induced even before Chk2-activation ( Figure 6 ) and that the subsequent alterations of gene expression and cellular responses were most likely the consequences of this property. The induction of gamma- H2AX is among the earliest indicators of DNA strand breaks (32) . In contrast, the activation of Chk2 by F3/4 and F2/13 ( Figure 4 ) correlated with the comparatively late activation of caspase 3, respectively ( Figure 6 ) that causes the degradation of DNA as one of several downstream effects. Cdc25A is a direct target of Chk2 and Chk1 and activation of Chk2 can cause the phosphorylation of Ser177 of Cdc25A, Chk1 the phosphorylation of Ser75 of Cdc25A, and both phosphorylations inactivate Cdc25A (33, 34) . F2/11 caused an intense phosphorylation of (Ser177)Cdc25A within 4 h and shortly after the activation of Chk2 (Figure 4) . Also (Ser75)Cdc25A became phosphorylated, but this was not due to Chk1 because this kinase did not become activated (data not shown). As a consequence, the phosphorylation level of (Tyr15)Cdc2 increased, because inactivated Cdc25A phosphatase did not resume to constitutively dephosphorylate this Cdc2 site (35) . Thus, the kinase activity (1 x 10 5 cells/ml), grown for 24 hours, and incubated with 3µg/ml fraction F2/11, F2/13 and F3/4 for the specified periods of time. Then, isolated protein samples were subjected to 10 % SDS-PAGE separation and subsequent Western blot analysis using the indicated antibodies. Equal sample loading was controlled by Poinceau S staining and β-actin analysis. 5 cells/ml), grown for 24 hours, and incubated with 3µg/ml fraction F2/11, F2/13 and F3/4 for the specified periods of time. Then, isolated protein samples were subjected to 10 % SDS-PAGE separation and subsequent Western blot analysis using the indicated antibodies. Equal sample loading was controlled by Poinceau S staining and β-actin analysis.
of Wee1 prevailed, which gave rise to a transient accumulation of (Tyr15)Cdc2 phosphorylation upon treatment with F2/11 (36) .
In contrast, F2/13 caused the de-phosphorylation of (Ser177)Cdc25A and hence, its activation (37). This was reflected by the de-phosphorylation of (Tyr15)Cdc2 after 8 h. Cdc2 is mandatory for orchestrated G2-M transit. Cdc25A and Cdc25C de-phosphorylate Cdc2, which causes the activation of its kinase domain (30) . Cdc2 protein levels were much more stable in cells treated with F2/13 than in those treated with F2/11. In fact, Cdc2 was undetectable upon treatment with F2/11 after 24 h, such as Cyclin D1, and this was most likely causal for cessation of cell proliferation.
F3/4 caused a very transient phosphorylation of (Ser177)Cdc25A and a weak but more sustained phosphorylation of (Ser75)Cdc25A, which correlated with the degradation of this protein after 24 h, and with a slight increase of (Tyr15)Cdc2 phosphorylation levels ( Figure 4) . We investigated, whether the stress response protein p38/MAPK may have caused phosphorylation of (Ser75)Cdc25A (38) . However, constitutive p38 phosphorylation levels were even reduced upon treatment with F3/4 (data not shown). After 24 h the lack of detectable (Tyr15)Cdc2 phosphorylation suggested that this cell cycle protagonist was fully activated. Therefore, suppression of Cyclin D1 together with the activation of Cdc2, as it was observed upon treatment with F3/4 and F 2/13, caused conflicting signals regarding an orchestrated cell cycle progression.
Fractions F2/11, F2/13 and F3/4 induce apoptosis
Since fractions F2/11, F2/13, and its derivative F3/4 were the most potent inhibitors of proliferation, they were also studied regarding their pro-apoptotic activities. We analyzed apoptosis with a highly sensitive method that identifies very early hallmark phenotypes long before the metabolism collapses and cells actually die (14) (15) (16) .
HL-60 cells were incubated with the indicated concentrations of the respective fractions (F2/11, F2/13, F2/14, F2/15, F3/4), and with 35 µg/ml of P. odorata CH 2 Cl 2 crude extract for 24 h, to investigate cell death induction. For the CH 2 Cl 2 crude extract ,the calculated concentration which induced 50 % apoptosis (A IC50 ) was ~25µM ( Figure 5 ). Fraction F2/11 and F3/4 were the most potent fractions, inducing 100 % apoptosis. Interestingly, F2/13, which was the precursor of F3/4, induced only 40 % apoptosis, similar to F2/15, and F2/14 was ineffective at the tested concentration. To unravel which of the two fractions was more potent, further dilutions to 1.5 µg/ml, 0.8 µg/ml, and 0.4 µg/ml enabled to calculate the A IC50 after 24 h, which was ~1.4 µg/ml for fraction F2/11 and ~0.6 µg/ml for fraction F3/4. In addition, fraction F2/11 und F3/4 were analyzed after 8 h of treatment and the results indicated F3/4 to be twice as active as F2/11 (Table 4) . Therefore, in fraction F3/4 the pro-apoptotic activity was 45-fold enriched compared to the crude CH 2 Cl 2 extract ( Figure 5 ).
Since in F3/4 the anti-proliferative and proapoptotic activities accumulated, we tested, whether an anti-migratory/metastatic property was contained as well and assessed F3/4 in a novel anti-metastasis assay based on the formation of gaps in lymphendothelial cell monolayers generated by MCF-7 breast cancer cell spheroids (39) . However, F3/4 did not prevent the formation of gaps (data not shown). 
Western blot analysis of apoptosis related proteins
When HL-60 cells were treated with 3 µg/ml of the indicated fractions, the cleavage of caspase 3 to a 19 kDa and a 12 kDa fragment was observed, which is a prerequisite for its activation that was confirmed by signature type cleavage of the downstream target PARP (40) . F2/11 caused the induction of gamma-H2AX within 30 minutes ( Figure 6 ) followed by the rapid activation of Chk2 (Figure 4) , thereby indicating genotoxicity and the presence of a DNA targeting component in F2/11. In contrast, F2/13 induced gamma-H2AX after 24 h and F3/4 after 8 h, which correlated with caspase 3 activity ( Figure  6 ). In this case, the induction of gamma-H2AX, and also the activation of Chk2 (Figure 4) , were most likely the consequence of the activation of Caspase-ActivatedDNAse (CAD) through caspase 3 (41).
Fractions F2/11, F2/13, and F3/4 induced the acetylation of alpha-tubulin and therefore, the stabilization of microtubule (42) (43) (44) . This was reminiscent of the mechanism of taxol that causes mitotic arrest (3, 4) . Tilting the fine-tuned equilibrium of polymerized/de-polymerized microtubule is incompatible with normal cell division and this causes cell cycle arrest and apoptosis (5) , and therefore, tubulin-targeting drugs are validated anti-cancer therapeutics (45) . The effect of fraction F2/11 differed from those of fractions F2/13 and F3/4 in that the acetylation of tubulin was rapid and severe upon treatment with F2/11, whereas fraction F2/13 induced tubulin acetylation only after 24 h and less pronounced. F3/4 induced tubulin acetylation already after 8 h which correlated with the enrichment of bio-activity compared to F2/13 ( Figure 6 ). Therefore, we could separate two very distinct antineoplastic properties in fractions that were derived from the P. odorata CH 2 Cl 2 crude extract. Firstly, a genotoxic property in fraction F2/11, which also triggered strong tubulin polymerization and which was certainly causal for both, cell cycle arrest and apoptosis. Secondly, an even stronger pro-apoptotic property in F3/4, which had more impact on the expression of the oncogenes Cyclin D1 and Cdc25A. The conflicting signals generated by cyclin D1 suppression and Cdc2 activation would specifically affect constantly cycling cancer cells. This was confirmed in experiments utilizing slowly cycling normal human lung fibroblasts, which were affected significantly less by fraction F3/4 than by fraction F2/11 (data not shown).
Previous studies on the genus Pluchea showed that the methanol extracts of P. odorata exhibited activity against Giardia lamblia trophozoites (46), and in the methanol extract of P. indica plucheol A and B, which are unique to species of Pluchea, were discovered (47) . From the chloroform extract of P. arabia, godotol A and B were isolated, which exert weak anti-bacterial activity (48) . In addition, in the chloroform extract of the aerial parts of P. sagittalis, the eudesmane-type sesquiterpenoids cuauthemone was found, which has anti-feedant activity (49) , and cuauthemone, pluchin, plucheinol, among other eudesmanetype sesquiterpenoids, were isolated from P. chingaio (50) . Cuauthemone was furthermore found in P. odorata (51) , and thus, cuauthemone is a likely constituent of the dichloromethane extract, which was shown to exert antiinflammatory activity (11, 52) . Flavonoids are well known for their anti-oxidant, anti-inflammatory, and anti-neoplastic effects and quercetin and isorhamnetin have been found in the leaves of P. lanceolata (53) . It is however unlikely, that polar flavonoids were contained in the here described dichloromethane extract of P. odorata. In a broad search for eudesmane-type sesquiterpenoids in the Asteraceae family only eudesmane ketones were found in P. odorata (54, 55) . Whether cuauthemone or other eudesmane ketones may have contributed to the anti-neolpastic effects of the here studied fractions of the P. odorata dichloromethane extract remains to be established. The TLC profile after detection with anisaldehyde sulphuric acid reagent proposes the presence of sesquiterpenes in the active fractions.
This study evidenced that the traditional Maya healing plant P. odorata used for the treatment of severe and chronic inflammations, has also anti-neoplastic potential. The separation of a genotoxic property in F2/11 from a cell cycle-interfering property in F3/4 is a relevant step to rid off extract components that may cause unspecific and therefore, undesired therapeutic side effects.
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